3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
24
Phase 3
9
Phase NA
4
Phase 4
3
Phase 2/3
3
Phase 1/2
3
Phase EARLY_PHASE1
1
Phase 1
1
Status
Unknown
2
Active not recruiting
1
Sponsor Class
OTHER
54
INDUSTRY
29
NIH
6
NETWORK
5
OTHER_GOV
3
UNKNOWN
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Oesophagogastric Cancer
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Interventions
Bevacizumab
4
Zoledronic Acid
3
Cisplatin
3
Capecitabine
3
spartalizumab
2
anlotinib
2
Radiotherapy
2
Positron Emission Tomography Computed Tomography
2
Metformin
2
Letrozole
2
Drug Therapy
2
vosaroxin
1
venetoclax
1
tislelizumab
1
pembrolizumab
1
enzalutamide
1
empagliflozin
1
atezolizumab
1
apatinib
1
abiraterone
1
XELOX
1
Vacuum Curettage
1
Tyrosine Kinase Inhibitors
1
Tuberculin
1
Sorafenib
1
Sodium Chloride
1
S 1 (combination)
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Prednisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2/3
×
OTHER_GOV
×
Cisplatin
×
Clear all
NCT02867865
2025-03-13
POLCAGB
Tata Memorial Hospital
Phase 2/3
Active not recruiting
124 enrolled
NCT02741856
2018-10-25
SCOPE2
Velindre NHS Trust
Phase 2/3
Unknown
584 enrolled
NCT00450203
2016-12-01
ST03
Medical Research Council
Phase 2/3
Unknown
1,103 enrolled